OA03.08 Trilaciclib Reduces the Need for Growth Factors and Red Blood Cell Transfusions to Manage Chemotherapy-Induced Myelosuppression

Autor: Purkalne, G., Ferrarotto, R., Anderson, I., Medgyasszay, B., García-Campelo, M.R., Edenfield, W., Feinstein, T., Johnson, J., Kalmadi, S., Lammers, P., Hernandez, A.S., Pritchett, Y., Malik, R.K., Morris, S.R., Csőszi, T.
Zdroj: In Journal of Thoracic Oncology January 2021 16(1) Supplement:S4-S4
Databáze: ScienceDirect